Loading…
Japanese maker of dental handpieces and precision dental/medical equipment used by dentists worldwide.
Japanese maker of dental handpieces and precision dental/medical equipment used by dentists worldwide.
Sells high-speed handpieces under the NSK name mainly through dental distributors, with overseas markets together bigger than Japan, and earns from repairs and replacement as handpieces wear out.
In one line: A dental-equipment specialist like a smaller Dentsply Sirona unit.
Moat: narrow (process know-how, brand). Precision micro-motor engineering and brand trust among dentists built over decades.
Headquarters: Tochigi, Japan · Founded: 1930 · Employees: 2,204
Size Nakanishi (7716.T) is a Japan Health Care company (Medical Specialties) with a market value of $1.42B, the 590th largest of 1,379 Japan companies the cockpit tracks. Shares closed at ¥2,994 on 6 Nov 2026.
Performance Over six months the shares gained 8.0%, against -6.7% for the median peer and +1.8% for the Japan market (cap-weighted) — 9th highest of 21 in its peer set.
Growth Revenue grew 14.9% over the last twelve months (peer median +7.3%); the operating margin is 18.5% (peer median 7.0%).
Valuation It trades at 16.3× forward earnings against a peer median of 23.6× (5th cheapest of 18).
Price implies For today's price to make sense, revenue must grow about 2% a year for seven years (Req g). Recent delivered growth is +20%, so the hurdle is -17 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 4.3 points above its cost of capital (7.2% WACC).
Next results Next results expected around 13 Nov 2026 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ¥89.2B | ¥81.2B | ¥77.0B | ¥59.7B | ¥48.7B |
| Revenue growth | — | +5% | +29% | +23% | — |
| Gross profit | ¥49.0B | ¥42.2B | ¥40.4B | ¥34.1B | ¥30.4B |
| EBITDA | ¥22.3B | ¥19.9B | ¥20.5B | ¥17.7B | ¥17.5B |
| Net income | ¥2.24B | -¥2.40B | ¥8.58B | ¥22.8B | ¥12.5B |
| Free cash flow | n/a | ¥12.3B | ¥10.5B | ¥2.93B | ¥4.29B |
| Capital expenditure | n/a | ¥5.31B | ¥5.25B | ¥5.95B | ¥3.98B |
| Total debt | ¥33.9B | ¥26.8B | ¥18.7B | ¥11.7B | ¥481M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Nakanishi 7716.T | $1.42B | +8% | +15% | 19% | 16.3× | 2.2% |
| DENTSPLY SIRONA XRAY | $1.89B | -14% | -1% | 5% | 7.3× | 10.2% |
| Morita 6455.T | $660M | -6% | 0% | 12% | 10.0× | -13.0% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 7716.T | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -3.7% | +5.2% | 6th lowest of 21 |
| 6-month return | +8.0% | -6.7% | 9th highest of 21 |
| Distance from 52-week high | -11.6% | -29.1% | 4th highest of 21 |
| Revenue growth (TTM) | +14.9% | +7.3% | 8th highest of 20 |
| Operating margin | 18.5% | 7.0% | 7th highest of 20 |
| Forward P/E | 16.3× | 23.6× | 5th cheapest of 18 |
| Growth the price implies (Req g, 7 yrs) | 2.2% | 10.8% | 3rd least demanding of 13 |
| Growth delivered (Del g) | +19.7% | +20.4% | 7th highest of 13 |
| Hurdle (Req g minus delivered) | -17.5 pp | -5.2 pp | 4th least demanding of 13 |
| ROIC minus cost of capital | +4.3 pp | +0.9 pp | 7th highest of 20 |
| EV / EBITDA | 9.0× | 11.1× | 3rd cheapest of 9 |
| Net debt / EBITDA | -1.0× | 0.1× | 5th least indebted of 10 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Nakanishi 7716.T | Japan | $1.42B | +8% | +15% | 19% | 16.3× | 2.2% | +19.7% |
| Ovctek China 300595.SZ | China | $1.42B | -26% | 0% | 28% | 20.8× | 9.9% | +16.5% |
| Sonoscape Medical 300633.SZ | China | $1.42B | -8% | +18% | 4% | 36.8× | n/a | n/a |
| El.En ELN.MI | Italy | $1.44B | +11% | +3% | 15% | 21.8× | 9.8% | +7.7% |
| Suzhou Sepax Technologies 688758.SS | China | $1.45B | +19% | +28% | 40% | 50.8× | 24.7% | +23.6% |
| Beijing Balance Medical Technology 688198.SS | China | $1.47B | -26% | +10% | 28% | 46.6× | 22.6% | +27.6% |
| Sansure Biotech 688289.SS | China | $1.36B | -8% | -1% | 1% | 39.0× | n/a | n/a |
| CONMED CNMD | United States | $1.53B | +40% | +2% | 2% | 11.1× | 32.4% | +9.8% |
| Shenzhen Edge Medical 2675.HK | Hong Kong | $1.31B | -51% | +132% | 2% | 130.1× | n/a | n/a |
| NovoCure NVCR | United States | $1.55B | -26% | +13% | -17% | n/a | n/a | n/a |
| NIPRO 8086.T | Japan | $1.55B | -9% | +3% | 6% | 14.9× | n/a | n/a |
| Enovis ENOV | United States | $1.57B | +2% | +5% | 3% | 7.7× | 22.3% | -6.0% |
| Sinocare 300298.SZ | China | $1.58B | +15% | +7% | 6% | 23.6× | 10.8% | +18.3% |
| Alpha Tau Medical DRTS | United States | $1.27B | +61% | n/a | n/a | n/a | n/a | n/a |
| Eyebright Medical Technology (Beijing) 688050.SS | China | $1.27B | -15% | +21% | 16% | 25.2× | 10.8% | +40.3% |
| Shanghai MicroPort Endovascular MedTech 688016.SS | China | $1.59B | -14% | +16% | 44% | 17.2× | 3.1% | +23.4% |
| STAAR Surgical STAA | United States | $1.26B | -6% | +51% | 18% | 45.8× | n/a | n/a |
| Guangzhou Hexin Instrument 688622.SS | China | $1.26B | +58% | -29% | -74% | n/a | n/a | n/a |
| CLASSYS 214150.KS | South Korea | $1.25B | -54% | +25% | 46% | 12.1× | -8.7% | +34.5% |
| Nihon Kohden 6849.T | Japan | $1.63B | +8% | +1% | 7% | 17.6× | -2.1% | +3.3% |
| Vitrolife VITR.ST | Sweden | $1.63B | +14% | -2% | 19% | 27.6× | 22.0% | +22.5% |